Showing 1 - 10 of 39
On 28 September 2022, the European Commission (EC) published its much-awaited proposals to significantly reform the EU Product Liability Directive (85/374/EEC) (PLD). The existing PLD came into force in July 1985 and has been the mainstay law governing redress for defective products across the EU. The legislation imposes a strict liability for defective products which have caused a loss to consumers.
Environmental, social and governance (ESG)-type obligations are increasingly imposed on actors in the modern product supply chain. Such obligations impact all stages of the product lifecycle and additionally impose subject-matter specific reporting obligations on companies in respect of these matters.
In an era of growing eco awareness an increasing number of companies are making environmental and sustainability claims about their practices, products and services. However, a recent international analysis of websites found that 40% of green claims made online could be misleading.
The ‘responsible’ Responsible Person – the complexities of ESG product compliance obligations for the life sciences industry
Whilst environmental and social governance (ESG) issues and related concepts are increasingly mainstay product compliance requirements to bring products to market in Europe, the life sciences industry continues to grapple with the unique challenges it faces when seeking to navigate, and apply, several broad-brush product compliance requirements to life sciences products.
As discussed at our recent panel discussion, ‘All for one and one for all – today’s diverse and inclusive products: legalities, risks and AI’, diversity, equality and inclusion (DEI) must be taken into account at each stage of the product lifecycle including product design, product testing, and product use.
The European Commission’s public consultation on the EU Cosmetics Products Regulation to run until 21 June 2022.
Promoting fairness in the digital market: EU Parliament and Member States reach agreement on EU Digital Markets Act
On 24 March 2022, EU legislators reached political agreement on the long awaited Digital Markets Act (DMA) which seeks to regulate ‘gatekeeper’ technology giants and a promote fair and open digital market.
In this report, Kennedys experts highlight recent legal and regulatory developments in the product safety and product liability sphere, and provide an overview of the key topics and trends that are likely to impact upon corporates and their insurers in the months ahead.
Since the UK’s exit from the European Union, the Medicines and Healthcare products Regulatory Agency (MHRA) has provided guidance on the regulation of medical devices and the requirements for their entry into the UK market.
EU pharmaceutical strategy: Member States welcome European Commission’s adoption of regulation on Health Technology Assessment
The long awaited regulation on Health Technology Assessment (HTA), adopted on 13 December 2021 and published in the EU Official Journal on 22 December 2021, is a deliverable of the EU Pharmaceutical Strategy that aims to revolutionise patient access to vital and innovative technologies.